A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide

References

• HajjarIKotchenTATrends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000JAMA2003290219920612851274
   PubMed Web of Science ®Google Scholar
• GuoFHeDZhangWWaltonRGTrends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010J Am Coll Cardiol201260759960622796254
   PubMed Web of Science ®Google Scholar
• OkonofuaECSimpsonKNJesriARehmanSUDurkalskiVLEganBMTherapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goalsHypertension200647334535116432045
   PubMed Web of Science ®Google Scholar
• WangSBerbariNChoiDManaging hypertension in patients with or without comorbidities in a teaching hospital outpatient settingP&T20073213242
   Google Scholar
• GradmanAHBasileJNCarterBLBakrisGLCombination therapy in hypertensionJ Am Soc Hypertens201041425020374950
   PubMed Web of Science ®Google Scholar
• CorraoGNicotraFParodiACardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practiceHypertension201158456657221825231
   PubMed Web of Science ®Google Scholar
• GradmanAHPariséHLefebvrePFalveyHLafeuilleMHDuhMSInitial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort studyHypertension201361230931823184383
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J200728121462153617562668
   PubMed Web of Science ®Google Scholar
• ManciaGLaurentSAgabiti-RoseiEReappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documentJ Hypertens200927112121215819838131
   PubMed Web of Science ®Google Scholar
• ONTARGET InvestigatorsYusufSTeoKKTelmisartan, ramipril, or both in patients at high risk for vascular eventsN Engl J Med2008358151547155918378520
   PubMed Web of Science ®Google Scholar
• [No authors listed]Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsLancet2000355920025325910675071
   PubMed Web of Science ®Google Scholar
• Di SommaSSentimentaleANew onset of type 2 diabetes mellitus during antihypertensive therapyHigh Blood Press Cardiovasc Prev20061312936
   Google Scholar
• CorraoGZambonAParodiADiscontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in ItalyJ Hypertens200826481982418327094
   PubMed Web of Science ®Google Scholar
• LacourcièreYA multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged ≥65 years with mild to moderate hypertensionClin Ther200022101213122411110232
   PubMed Web of Science ®Google Scholar
• BurnierMMaillardMThe comparative pharmacology of angiotensin II receptor antagonistsBlood Press Suppl2001161111333013
   PubMedGoogle Scholar
• Boehringer IngelheimMicardis [summary of product characteristics]Ingelheim GermanyBoehringer Ingelheim International2008
   Google Scholar
• Boehringer IngelheimMicardis [prescribing information]Ingelheim, GermanyBoehringer Ingelheim International2012
   Google Scholar
• GradmanAHBasileJNCarterBLBakrisGLCombination therapy in hypertensionJ Clin Hypertens (Greenwich)201113314615421366845
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med2008359232417242819052124
   PubMed Web of Science ®Google Scholar
• BakrisGLSarafidisPAWeirMRRenal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialLancet201037597211173118120170948
   PubMed Web of Science ®Google Scholar
• MallatSGWhat is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?Cardiovasc Diabetol2012113222490507
   PubMed Web of Science ®Google Scholar
• ChalmersJJoshiRKengneAPMacMahonSBlood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCEJ Hypertens Suppl2008262S11S1518979718
   PubMedGoogle Scholar
• PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attackLancet200135892871033104111589932
   PubMed Web of Science ®Google Scholar
• BeckettNSPetersRFletcherAETreatment of hypertension in patients 80 years of age or olderN Engl J Med2008358181887189818378519
   PubMed Web of Science ®Google Scholar
• BulpittCJBeckettNSPetersRBlood pressure control in the Hypertension in the Very Elderly Trial (HYVET)J Hum Hypertens201226315716321390056
   PubMed Web of Science ®Google Scholar
• NeldamSLangMJonesRTelmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 studyJ Clin Hypertens (Greenwich)201113745946621762357
   PubMed Web of Science ®Google Scholar
• NeldamSSchumacherHGuthrieRTelmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressuresAdv Ther201229432733822477543
   PubMed Web of Science ®Google Scholar
• NeutelJMManciaGBlackHRSingle-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN studyJ Clin Hypertens (Greenwich)201214420621522458741
   PubMed Web of Science ®Google Scholar
• LittlejohnTWIIIMajulCROlveraRTelmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 × 4 factorial studyPostgrad Med2009121251419332958
   PubMed Web of Science ®Google Scholar
• NeldamSDahlofBOigmanWSchumacherHEarly combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goalsInt J Clin Pract2013
   PubMed Web of Science ®Google Scholar
• LacourcièreYTytusRO’KeefeDLenisJOrchardRMartinKEfficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapyJ Hum Hypertens2001151176377011687919
   PubMed Web of Science ®Google Scholar
• LacourcièreYA new fixed-dose combination for added blood pressure control: telmisartan plus hydrochlorothiazideJ Int Med Res200230436637912235918
   PubMed Web of Science ®Google Scholar
• LacourcièreYMartinKComparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertensionAm J Ther20029211111711897925
   PubMedGoogle Scholar
• McGillJBReillyPATelmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trialClin Ther200123683385011440284
   PubMed Web of Science ®Google Scholar
• NeldamSEdwardsCResults of increasing doses of hydrochlorothiazide in combination with an angiotensin receptor blocker in patients with uncontrolled hypertensionJ Clin Hypertens (Greenwich)200810861261818772643
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034261206125214656957
   PubMed Web of Science ®Google Scholar
• ZhuDLBaysHGaoPMattheusMVoelkerBRuilopeLEfficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trialClin Ther20123471613162422717420
   PubMed Web of Science ®Google Scholar
• WhiteWBLittlejohnTWMajulCREffects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1–2 hypertensionBlood Press Monit201015420521220613496
   PubMed Web of Science ®Google Scholar
• ParatiGBiloGRedonJThe effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2)Hypertens Res201236432232723154590
   PubMed Web of Science ®Google Scholar
• BekkiHYamamotoKSoneMEfficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertensionOxid Med Cell Longev20103534234621150340
   PubMed Web of Science ®Google Scholar
• BekkiHYamamotoKSoneMBeneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertensionClin Cardiol201134426126521432858
   PubMed Web of Science ®Google Scholar
• WhiteWBPunziHAMurwinDKovalSEDavidaiGNeutelJMEffects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertensionJ Clin Hypertens (Greenwich)20068962663316957424
   PubMedGoogle Scholar
• WhiteWBMurwinDChrysantSGKovalSEDavidaiGGuthrieREffects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trialBlood Press Monit2008131212718199920
   PubMed Web of Science ®Google Scholar
• WhiteWBDavidaiGSchumacherHImpact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1–2 hypertensionJ Hum Hypertens2009231281782519357698
   PubMed Web of Science ®Google Scholar
• LacourcièreYGil-ExtremeraBMuellerOByrneMWilliamsLEfficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertensionInt J Clin Pract200357427327912800457
   PubMed Web of Science ®Google Scholar
• LacourcièreYNeutelJMSchumacherHComparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trialsClin Ther200527111795180516368450
   PubMed Web of Science ®Google Scholar
• NeutelJMLittlejohnTWChrysantSGSinghATelmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertensionHypertens Res200528755556316335883
   PubMed Web of Science ®Google Scholar
• SharmaAMDavidsonJKovalSLacourcièreYTelmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH studyCardiovasc Diabetol200762817910747
   PubMed Web of Science ®Google Scholar
• TakagiHMizunoYGotoSNUmemotoTA meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressureInt J Cardiol Epub11282012
   Web of Science ®Google Scholar
• FogariRDerosaGZoppiAEffect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuriaAm J Hypertens200720441742217386350
   PubMed Web of Science ®Google Scholar
• MaLWangWZhaoYCombination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety studyAm J Cardiovasc Drugs201212213714222329591
   PubMed Web of Science ®Google Scholar
• SharmaAMBakrisGNeutelJMSingle-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trialClin Ther201234353755122386829
   PubMed Web of Science ®Google Scholar
• GuthrieRMDahlofBJamersonKAEfficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patientsCurr Med Res Opin201127101995200821905967
   PubMed Web of Science ®Google Scholar
• LeyLSchumacherHTelmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)Curr Med Res Opin2013291415323157465
   PubMed Web of Science ®Google Scholar
• ZhuDLBaysHGaoPMattheusMVoelkerBRuilopeLEfficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, sex, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trialIntegr Blood Press Control2013611423637556
   PubMedGoogle Scholar
• BaysHGaoPVoelkerBMattheusMRuilopeLZhuDEfficacy of single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg in patients with cardiovascular disease risk factors: a prospective subgroup analysis of a randomized, double-blind, controlled trialInt J Hypertens2013201374983010.1155/2013/74983023653855
   PubMedGoogle Scholar
• KjeldsenSESchumacherHNeldamSGuthrieRMTelmisartan/hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patientsJ Clin Hypertens (Greenwich)201315638038823730986
   PubMed Web of Science ®Google Scholar
• GarberAJHandelsmanYEinhornDDiagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical EndocrinologistsEndocr Pract200814793394618996826
   PubMedGoogle Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J Epub6142013
   Google Scholar
• ChrysantSGAmlodipine/ARB fixed-dose combinations for the treatment of hypertension: focus on amlodipine/olmesartan combinationDrugs Today (Barc)200844644345318596998
   PubMed Web of Science ®Google Scholar
• FlackJMSicaDABakrisGManagement of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statementHypertension201056578080020921433
   PubMed Web of Science ®Google Scholar
• NeutelJMSmithDHReillyPAThe efficacy and safety of telmisartan compared to enalapril in patients with severe hypertensionInt J Clin Pract199953317517810665127
   PubMed Web of Science ®Google Scholar
• MeredithPAAngiotensin II receptor antagonists alone and combined with hydrochlorothiazide: potential benefits beyond the antihypertensive effectAm J Cardiovasc Drugs20055317118315901205
   PubMedGoogle Scholar
• TaylorENHuFBCurhanGCAntihypertensive medications and the risk of incident type 2 diabetesDiabetes Care20062951065107016644638
   PubMed Web of Science ®Google Scholar
• SalvettiAGhiadoniLThiazide diuretics in the treatment of hypertension: an updateJ Am Soc Nephrol2006174 Suppl 2S25S2916565243
   PubMed Web of Science ®Google Scholar
• BasileJNAntihypertensive therapy, new-onset diabetes, and cardiovascular diseaseInt J Clin Pract200963465666619220522
   PubMed Web of Science ®Google Scholar
• YoshimuraMKawaiMSynergistic inhibitory effect of angiotensin II receptor blocker and thiazide diuretic on the tissue renin-angiotensin-aldosterone systemJ Renin Angiotensin Aldosterone Syst201011212412620194569
   PubMed Web of Science ®Google Scholar
• LiuZDietary sodium and the incidence of hypertension in the Chinese population: a review of nationwide surveysAm J Hypertens200922992993319661928
   PubMed Web of Science ®Google Scholar
• LittlejohnTWIIIMajulCROlveraRResults of treatment with telmisartan-amlodipine in hypertensive patientsJ Clin Hypertens (Greenwich)200911420721319614805
   PubMed Web of Science ®Google Scholar
• PloskerGLWhiteWBTelmisartan/hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertensionDrugs200868131877189918729541
   PubMed Web of Science ®Google Scholar
• SchumacherHManciaGThe safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studiesBlood Press Suppl20081324018705533
   PubMedGoogle Scholar
• CerezoCSevillanoAGuerreroLDoes hypertensive patient fenotype influence when selecting the best combination of antihypertensive drugs?Journal of Hypertension31e-Supplement A62013
   Google Scholar
• SeverPSMesserliFHHypertension management 2011: optimal combination therapyEur Heart J201132202499250621697169
   PubMed Web of Science ®Google Scholar
• KjeldsenSEOsIHøieggenABeckeyKGleimGWOparilSFixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazideAm J Cardiovasc Drugs200551172215631534
   PubMedGoogle Scholar
• MakaniHBangaloreSRomeroJWever-PinzonOMesserliFHEffect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edemaAm J Med2011124212813521295192
   PubMed Web of Science ®Google Scholar
• OparilSWeberMAngiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapyPostgrad Med20091212253919332960
   PubMed Web of Science ®Google Scholar
• de la SierraAMitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin systemJ Hum Hypertens200923850351119148104
   PubMed Web of Science ®Google Scholar
• PedrinelliRDell’OmoGMarianiMCalcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertensionJ Hum Hypertens200115745546111464254
   PubMed Web of Science ®Google Scholar
• WeberMAJuliusSKjeldsenSEBlood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trialLancet200436394262049205115207957
   PubMed Web of Science ®Google Scholar
• KjeldsenSEMesserliFHChiangCEMeredithPALiuLAre fixed-dose combination antihypertensives suitable as first-line therapy?Curr Med Res Opin201228101685169722978777
   PubMed Web of Science ®Google Scholar
• EganBMBandyopadhyayDShaftmanSRWagnerCSZhaoYYu-IsenbergKSInitial monotherapy and combination therapy and hypertension control the first yearHypertension20125961124113122566499
   PubMed Web of Science ®Google Scholar
• MazzagliaGAmbrosioniEAlacquaMAdherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patientsCirculation2009120161598160519805653
   PubMed Web of Science ®Google Scholar
• GuptaAKArshadSPoulterNRCompliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysisHypertension201055239940720026768
   PubMed Web of Science ®Google Scholar
• GerbinoPPShoheiberOAdherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agentsAm J Health Syst Pharm200764121279128317563050
   PubMed Web of Science ®Google Scholar
• ZengFPatelBVAndrewsLFrech-TamasFRudolphAEAdherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimensCurr Med Res Opin201026122877288721067459
   PubMed Web of Science ®Google Scholar
• DicksonMPlauschinatCACompliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapyAm J Cardiovasc Drugs200881455018303937
   PubMed Web of Science ®Google Scholar
• ChangJYangWFellersTChart review of patients on valsartan-based single-pill combinations vs ARB-based free combinations for BP goal achievementCurr Med Res Opin20102692203221220673201
   PubMed Web of Science ®Google Scholar
• BangaloreSLeyLImproving treatment adherence to antihypertensive therapy: the role of single-pill combinationsExpert Opin Pharmacother201213334535522220825
   PubMed Web of Science ®Google Scholar